SILO · Forms 3, 4, 5
Insider trades at Silo Pharma, Inc.
No open-market insider buys or sells at Silo Pharma, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Silo Pharma, Inc. (SILO) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Silo Pharma, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Eric Weisblum | Chief Executive Officer | Buy | 2,500 | $0.41 | $1K | Form 4 | |
| Eric Weisblum | Chief Executive Officer | Buy | 2,500 | $0.42 | $1K | Form 4 | |
| Eric Weisblum | Chief Executive Officer | Buy | 1,000 | $0.37 | $365 | Form 4 | |
| Eric Weisblum | Chief Executive Officer | Buy | 1,000 | $0.37 | $370 | Form 4 | |
| Eric Weisblum | Chief Executive Officer | Buy | 4,500 | $0.41 | $2K | Form 4 | |
| Eric Weisblum | Chief Executive Officer | Buy | 7,500 | $0.40 | $3K | Form 4 | |
| Eric Weisblum | Chief Executive Officer | Buy | 10,000 | $0.43 | $4K | Form 4 | |
| Wayne Linsley | Director | Options or other derivatives | Form 4 | ||||
| Kevin Munoz | Director | Options or other derivatives | Form 4 | ||||
| Daniel E. Ryweck | Chief Financial Officer | Options or other derivatives | Form 4 | ||||
| Eric Weisblum | Chief Executive Officer | Options or other derivatives | Form 4 | ||||
| Jeff Pavell | Director | Options or other derivatives | Form 4 | ||||
| Eric Weisblum | CEO and President | Buy | 2,500 | $0.84 | $2K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.